Biopharma leaders soon will learn to partner with wearable AI systems to facilitate communication and decision-making in ...

Samsung Biologics secures $262m manufacturing deal with European pharma as it expands Bio Campus II at Songdo to 720 kL by ...

AI tools are reshaping drug development and manufacturing, but their effectiveness depends on robust data and human ...

A recent scientific report found almost 19,000 doctored images of antibodies available in the commercial market.

Next-gen AAV manufacturing can enable scalable, affordable gene therapies through producer cell lines, process ...

Large pharmaceutical firm Novartis confirmed that it is halting and investigating several clinical trial programs involving ...

Eli Lilly will acquire Merida Biosciences for up to $2.875 billion, gaining MER511, a Phase I therapy targeting ...

CAR T therapies face scalability challenges. An eXmoor consultant explores how synthetic approaches using lipid nanoparticles ...

As BIG Executive Summit participants reveal, biomanufacturing innovations often fail due to fragmented pathways for adoption, ...

Argentine biotech firm Biosidus tripled its cell culture capacity with a $12.9 million expansion to boost biosimilar ...

Human-in-the-loop models could provide a credible and scalable path forward for using agentic AI in biopharma commercial ...

Large-scale validation of regenerative medicine, especially based on cell therapies, may come from cell therapies developed ...